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SuperoxideAbstract Novel biomimetic ligands were synthesized by the condensation of 3-hydroxyﬂavone,
2-aminophenol(L1)/2-aminobenzoic acid (L2) and-aminothiazole (L3). Their Cu(II) complexes have
also been synthesized and characterized on the basis of 1H NMR, IR, UV–Vis spectra, elemental
analyses, molar conductivity, ESR, electrochemical behaviour and thermal analyses. The antimicro-
bial activities (MIC values) of the ligands, copper complexes and standard drugs have been
evaluated using the serial dilution technique against the bacterial species Staphylococcus aureus,
Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris and Pseudomonas aeruginosa and fungal
species Aspergillus niger, Rhizopus stolonifer, Aspergillus ﬂavus, Rhizoctonia bataicola and Candida
albicans. The anti-inﬂammatory and SOD activities of the investigated compounds are also prom-
ising and allow the selection of a lead compound for further biological studies.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Flavones occupy a special place in the realm of natural and
synthetic organic chemistry owing to their useful biologicalactivities such as anti-oxidant (Rice-Evans, 2001), Anxiolytic
(De Almeida et al., 2009), anti-cancer (Liu et al., 1992), anal-
gesic (Shin et al., 1999), and anti-microbial (Sohel et al.,
2006). During the past few years various methods have been
reported for the synthesis of ﬂavones (Diana, 2000; Kumar
and Perumal, 2007; Ballesteros et al., 1995).
The copper is an essential micronutrient for feeding and a
cofactor of several enzymes involved in oxidative metabolism
like b-hydroxylases, quercetinase, ceruloplasmine, cytochrom-
oxidase, monoaminoxidase, superoxydismutase, ascorbic acid
oxidase and tyrosinase (Berdanier et al., 1999; Brill et al.,
1964 and Frieden et al., 1965). The catalytical role of these
enzymes is a two-step process, i.e., the reduction of Cu2+
Pharmacological and spectral studies of synthetic biomimetic copper complexes derived from S549ion to Cu+ and the ﬁxation of molecular oxygen (Halfen
et al., 1996). The copper(II) complexes of multidentate Schiff
base ligands have played a vital role in the development of
coordination chemistry (Chiari et al., 2001; Swearingen and
West, 2001).
A range of monocarboxylic acids are known to have a
variety of pharmacological effects. Salicylic acid and its deriva-
tives, for example, have been shown to possess anti-inﬂamma-
tory and antitumour activity (Sorenson, 1976). Upon
coordination to a suitable metal centre, the biologically active
carboxylic acids often become more effective and desirable
drugs (Sorenson, 1989). The carboxylate group is an important
class of ligands in inorganic and bioinorganic chemistry, metal
complexes containing monocarboxylic acids are well known,
and the publication of many structurally characterised exam-
ples of this class of compound has demonstrated its versatility
as an inner-sphere ligand (Mehrotra and Bohra, 1983).
As part of our continuous investigations, we report here the
synthesis, structural aspects and biological studies of cop-
per(II) complexes of the above said Schiff base ligands. The
anti-inﬂammatory activity of the ligands and their complexes
has also been studied.2. Experimental
Analytical grade chemicals commercially available purchased
from BDH, Aldrich, Fischer etc were used for synthesis and
solvents were puriﬁed by standard methods.
Micro analytical data and FAB Mass spectra of the com-
pounds were recorded at the Regional Sophisticated Instru-
mentation Center, Central Drug Research Institute (RSIC,
CDRI), Lucknow. The amount of copper present in the copper
complexes was estimated using AAS. The NMR spectra of the
ligands were recorded using TMS as internal standard. Chem-
ical shifts (d) are expressed in units of parts per million relative
to TMS. The FAB mass spectrum of the ligands and their com-
plexes were recorded on a JEOL SX 102/DA-6000 mass spec-
trometer/data system using argon/xenon (6 kV, 10 mA) as the
FAB gas. The accelerating voltage was 10 kV and the spectra
were recorded at room temperature using m-nitrobenzylalco-
hol (NBA) as the matrix. Molar conductance of the copper
complexes was measured in DMSO solution using a corona-
tion digital conductivity metre. The IR spectra of the ligands
and their copper complexes were recorded on a Perkin-Elmer
783 spectrophotometer in 4000–200 cm1 range using KBr
disc. Electronic spectra were recorded with a Systronics 2201
Double beam UV–Vis, spectrophotometer in the 200–
1100 nm region. The magnetic susceptibility values were calcu-
lated using the relation leff = 2.83 (vm.T). The diamagnetic
corrections were made by Pascal’s constant and Hg[Co(SCN)4]
was used as a calibrant. The ESR spectra of the copper com-
plexes were recorded at 300 and 77 K on a Varian E112 X-
band spectrometer. Cyclic voltammetric measurements were
performed using a glassy carbon working electrode, Pt wire
auxiliary electrode and an Ag/AgCl reference electrode. Tetra-
butylammoniumperchlorate (TBAP) was used as the support-
ing electrolyte. All solutions were purged with N2 for 30 min
prior to each set of experiments. The computer controlled X-
ray diffractometer system JEOL JDX 8030 was used to record
powder data for the copper complexes, at the Central Electro-
chemical Research Institute, Karaikudi.2.1. Preparation of Ligand (L1–L3)
Equimolar amount of 3-hydroxyﬂavone and o-aminophenol
(L1)/o-aminobenzoic acid (L2)/o-aminothiazole (L3) was dis-
solved in ethanol (40 mL). Acetic acid (1.0 mL) was added to
this solution. The solution was stirred for 3 h and the precipi-
tate was formed. The precipitate was ﬁltered and washed with
water and ethanol.
L1: Yield: 60%. Anal. Calcd for C21H15NO3: C, 76.58; H,
4.59; N, 4.25. Found: C, 76.64; H, 4.62; N, 4.28. FAB mass
spectrometry (FAB-MS), m/z 330 [M+1]. 1H-NMR
(400 MHz, CDCl3) d: 6.6–7.8 (13H, m, Ar-H) and 11.2 and
10.8 (2H, s, O–H, D2O exchangeable, 3-hydroxyﬂavone
and o-aminophenol moities).13C-NMR (400 MHz, CDCl3,
ppm): 150.8 (C-2), 140.6 (C-3), 153.8 (C-4), 112.8(C-5),
145.6 (C-6), 124.4 (C-7), 126.9 (C-8), 156.6 (C-9), 118.8 (C-
10), 133.6 (C-1
0
), 124.3 (C-20, 60), 126.5 (C-30, 5
0
), 126.4 (C-
4
0
), 130.6 (C-1
0 0
), 115.2 (C-2
0 0
), 120.6 (C-3
0 0
), 119.2 (C-4
0 0
),
126.2 (C-5
0 0
) and 140.8 (C-6
0 0
).
L2: Yield: 65%. Anal. Calcd for C22H15NO4: C, 73.94; H,
4.23; N, 3.91. Found: C, 73.98; H, 4.26; N, 3.98. FAB
mass spectrometry (FAB-MS), m/z 358 [M+1]. 1H-
NMR (400 MHz, CDCl3) d: 6.7–7.9 (12H, m, Ar-H),
11.6 and 10.4 (2H, 13C-NMR (400 MHz, CDCl3, ppm):
149.4 (C-2), 110.2 (C-3), 154.5 (C‚N), 115.6 (C-5),
146.4 (C-6), 122.8 (C-7), 126.4 (C-8), 152.6 (C-9), 119.9
(C-10), 132.5 (C-1
0
), 125.4 (C-2
0
, 6
0
), 127.6 (C-3
0
, 5
0
),
126.5 (C-4
0
), 148.6 (C-1
0 0
), 113.4 (C-2
0 0
), 132.6 (C-3
0 0
),
116.5 (C-4
0 0
), 128.9 (C-5
0 0
), 140.8 (C-6
0 0
) and 168.2
(COOH).
L3: Yield: 62%. Anal. Calcd for C18H12N2O2S: C, 67.49; H,
3.78; N, 8.75. Found: C, 67.42; H, 3.72; N, 8.69. Fast atom
bombardment mass spectrometry (FAB-MS), m/z 322
[M+1]. 1H-NMR (400 MHz, CDCl3) d: 5.9–7.9 (13H,
m,Ar-H), 12.9 and 10.8 (2H, s, S–H & O-H, D2O exchange-
able). 13C-NMR (400 MHz, CDCl3): 149.4 (C-2), 110.2 (C-
3), 154.5 (C‚N), 115.6 (C-5), 147.4 (C-6), 122.6 (C-7),
126.9 (C-8), 154.6 (C-9), 121.9 (C-10), 132.5 (C-1
0
), 125.4
(C-2
0
, 6
0
), 127.6 (C-3
0
, 5
0
), 126.5 (C-4
0
), 158.6 (C-11), 103.4
(C-12) and 148.9 (C-13).
2.1.1. Preparation of copper complexes of Ligands (L1–L3)
The ligand (s) (0.05 mM) and copper acetate (0.05 mM) were
dissolved in acetone (20 mL). Under stirring, triethylamine
(0.075 mM) was then dropped to the mixture with caution.
After stirring for 4 h at room temperature, the precipitate
was separated, puriﬁed by washing several times with acetone
and dried in vacuum.
Complex of L1: Yield: 74%. Anal. Calcd for CuC21H17NO4:
C, 61.36; H, 4.17; N, 3.41, Cu, 15.47. Found: C, 61.31; H,
4.15; N, 3.36; Cu, 15.43. FAB mass spectrometry (FAB-
MS), m/z 411 [M+1]. leff (BM) = 1.92; Km (mhocm
2 mol
1) = 24.
Complex of L2: Yield: 79%. Anal. Calcd for CuC22H17NO5:
C, 60.18; H, 3.91; N, 3.19, Cu, 14.49. Found: C, 60.14; H,
3.86; N, 3.15; Cu, 14.43. FAB mass spectrometry (FAB-
MS), m/z [M+1]. leff (BM) = 2.06; Km (mhocm
2
mol1) = 29.
Figure 1 The proposed structures of ligands (L1-L3).
S550 K. Nagashri et al.Complex of L3: Yield: 76%. Anal. Calcd for CuC20H15-
N2O4S: C, 54.22; H, 3.42; N, 6.33; Cu, 14.36. Found: C,
74.62; H, 3.35; N, 6.29; Cu, 14.31. FAB mass spectrometry
(FAB-MS),m/z 443 [M+1]. leff (BM) = 1.98; Km (mhocm
2
mol1) = 8.
2.2. Biological studies
2.2.1. Antimicrobial activity
The in vitro antimicrobial activities of the investigated com-
pounds were tested against the bacterial species, Staphylococ-
cus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus
vulgaris and Pseudomonas aeruginosa and fungal species,
Aspergillus niger, Rhizopus stolonifer, Aspergillus ﬂavus, Rhizoc-
tonia bataicola and Candida albicans. One day prior to the
experiment, the bacterial and fungal cultures were inoculated
in broth (inoculation medium) and incubated overnight at
37 C. Inoculation medium containing 24 h grown culture
was added aseptically to the nutrient medium and mixed thor-
oughly to get the uniform distribution. This solution was
poured (25 mL in each dish) into petri dishes and then allowed
to attain room temperature. Wells (6 mm in diameter) were cut
in the agar plates using proper sterile tubes. Then, ﬁll wells
were ﬁlled up to the surface of agar with 0.1 mL of the test
compounds dissolved in DMSO (200 lM/mL). The plates were
allowed to stand for an hour in order to facilitate the diffusion
of the drug solution. Then the plates were incubated at 37 C
for 24 h for bacteria and 48 h for fungi and the diameter of
the inhibition zones were read. Minimum inhibitory concentra-
tions (MICs) were determined by using the serial dilution
method. The lowest concentration (lg/mL) of compound,
which inhibits the growth of bacteria after 24 h incubation at
37 C, and of fungi after 48 h incubation at 37 C was taken
as the MIC.
2.2.2. SOD activity
In vitro SOD activity was measured using alkaline DMSO as a
source of superoxide radical (O2 ) and nitrobluetetrazolium
(NBT) as O2 scavenger. In general, 400 lL sample to be as-
sayed was added to a solution containing 2.1 mL of 0.2 M
potassium phosphate buffer (pH 8.6) and 1 mL of 56 lM
NBT. The tubes were kept in ice for 15 min and then 1.5 mL
of alkaline DMSO solution was added while stirring. A unit
of superoxide dismutase [SOD] activity is the concentration
of complex or enzyme, which causes 50% inhibition of alkaline
dimethylsulfoxide (DMSO) mediated reduction of nitroblu-
etetrazolium chloride (NBT) (absorbance was then monitored
at 540 nm).
2.2.3. Anti-inﬂammatory studies
The anti-inﬂammatory activity of copper complexes was deter-
mined by using the carrageenan-induced paw oedema method.
Groups of ﬁve rats with masses of 180–220 g were used. A sus-
pension containing single dose of 0.01 mmol/kg body mass per
1 mL of the copper complexes, suspended in isotonic sterile
saline water, with few drops of Tween 80 and ground in a mor-
tar to suspend, was given IP at the same time as the phlogistic
agent, carrageenin. Carrageenin (2%) in 0.1 mL of isotonic
sterile saline water was injected intradermally into the right
foot pad, the left paw serving as control. Indomethacin, refer-ence drug, was administered IP, simultaneous with the admin-
istration of the phlogistic agent. Controls received the liquid
vehicle. These animals were euthanized 3.5 h after carrageenin
injection. Both hind paws were severed above the ankle joint
and immediately massed with a very sensitive analytical bal-
ance. The experiment was repeated for each compound with
a second group of ﬁve animals. The difference between masses
of the injected and uninjected paws was calculated for each
animal. The change in paw mass was compared with that for
control animals injected with isotonic sterile saline water and
expressed as percent inhibition of oedema, CPE% values in
Table 6.
3. Results and discussion
The Schiff bases (Fig. 1) are prepared as described in the exper-
imental part, crystallized and dried under vacuum and sub-
jected to elemental analyses. The results obtained are in
good agreement with those calculated for the suggested formu-
lae and the melting points are sharp indicating the purity of the
prepared Schiff bases. All complexes were decomposed above
280 C indicating their thermal stability.
3.1. Molar conductance
The molar conductance data for the copper complexes mea-
sured in DMSO solution for the 0.001 M solutions are given
in Section 2. The values of the complexes fall in the range of
8–29 X1 cm2 mol1, which is the expected range of 1–35 X
1 cm2 mol1 for the complexes to behave as non-electrolytes
(Geary, 1971). Thus, the complexes have non-electrolytic nat-
ure as evidenced by the involvement of the acetate group in
coordination. This result was conﬁrmed from the chemical
analysis of CH3COO
 ion not precipitated by addition of
FeCl3. The complexes did not show electrolytic properties.
Table 1 Electronic spectral data of ligands and their copper complexes.
S. no. Compound Solvent Absorption (nm) Band assignment Geometry
1 L1 DMSO 215 INCT –
312 INCT
2 L2 DMSO 232 INCT –
336 INCT
3 L3 DMSO 248 INCT –
342 INCT
4 [CuL1(H2O)] DMSO 228 INCT
342 INCT
578 2B1gﬁ 2A1g Square planar
5 [CuL2(H2O)] DMSO 248 INCT
342 INCT
530 2B1gﬁ 2A1g Square planar
6 [CuL3(H2O)] DMSO 254 INCT
348 INCT
572 2B1gﬁ 2A1g Square planar
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In order to study the binding mode of the Schiff base to the
metal in the complexes, the IR spectrum of the free ligand
was compared with the spectra of the complexes. The IR spec-
trum of the ligands shows a m(C‚N) peak in the region 1645–
1632 cm1. The IR spectra of all complexes show m(C‚N)
bands at 1629–1590 cm1 (Bansod et al., 2007) and it is found
that the m(C‚N) bands in the complexes are shifted to lower
energy regions compared to the free ligands. The shift of this
band towards energy side is probably caused by an increase
in the C‚N bond order due to the coordination of the nitro-
gen with the copper atom.
However, the spectra of complexes show two characteristic
bands at 1630–1602 and 1404–1344 cm1 attributed to tasy(-
COO) and tsy.(COO
), respectively, indicating the participa-
tion of the carboxylate oxygen atom in the complexes. The
mode of coordination of the carboxylate group has often been
deduced from the magnitude of the observed separation be-
tween the tasy(COO
) and tsy.(COO
), the separation value
(A) between tasy(COO
) and tsy.(COO
) in metal complexes
was more than 200 cm1 (260–216 cm1) which suggests the
coordination of the carboxylate group in copper complexes
of the ligands in a monodentate fashion (Nakamoto, 1988).
The Schiff base ligands display a band around 844 cm1 as-
cribed to t C–S (Sandipan Sarkar et al., 2009) which shifts
to lower frequencies in their spectra of copper complexes in
the region 838–832 cm1, respectively, suggesting the coordi-
nation of copper ions through the sulfur atom of the thioazole
moiety. The band at 3466 cm1 for t(OH) in the free ligand
disappeared on complexation, indicating coordination through
a deprotonated oxygen.
The band observed in the region 1534–1526 cm–1 is due to
the mC=C stretching of the aromatic ring system. In all the cop-
per-Schiff base complexes, most of the band shifts observed in
the wave number region 1142–980 cm1 are in agreement with
the structural changes observed in the molecular carbon skele-
ton after complexation, which cause some changes in the (C–
C) bond lengths. Conclusive evidence of the bonding is also
shown by the observation that new bands in the spectra ofall copper complexes appear in the low frequency regions at
550–516, 504–498 and 486–448 cm1 characteristic to t(M–O),
t(M–N) and t(M–S) stretching vibrations, respectively, that
are not observed in the spectra of free ligands (Anacona
et al., 2009). The IR bands at 810–854 and 784–799 cm1,
t(H2O) of coordinated water, is an indication of the binding
of the water molecules to the metal ions.
3.3. Electronic spectra
The electronic spectra of the Schiff base ligands and their cop-
per complexes in DMSO were recorded at room temperature
and the band positions of the absorption maxima; band assign-
ments and the proposed geometry are shown in Table 1. The
electronic spectra of the ligands and their complexes were re-
corded in DMSO as a solvent. The absorption spectrum for
L1 shows band at 225 and 312 nm. These bands can be
attributed to n–p*and p–p* transitions within the Schiff base
molecule. The electronic spectrum of the corresponding
[CuL1(H2O)] complex in DMSO reveals a broad band at
558 nm assignable to 2B1gﬁ2A1g transition (Chandra and
Gupta, 2005) which is characteristic of square planar environ-
ment around the copper(II) ion. Similar spectral features were
assigned for other complexes.
The electronic spectra of all the complexes exhibit bands in
the regions 200–225, 272–332 and 362–390 nm, which may be
due to the p–p* transition of the benzenoid/or n–p* (COO),
p–p* transition of the >C‚N– chromophore and n–p* transi-
tion of the >C‚N– chromophore, coupled with the second-
ary band of the benzene ring, respectively. Further, there
were a few sharp bands observed in the region 233–257 nm
in the spectra of the complexes, which could be assigned as
charge transfer bands.3.4. NMR spectra
The 1H and 13C-NMR spectrum of ligands were recorded in
CDCl3 and are given in Section 2. All the protons were found
as to be in their expected region (Li et al., 2008). The conclu-
Figure 2 FAB mass spectrum of Ligand (L1).
Figure 3 FAB mass spectrum of [CuL1(H2O)] complex.
S552 K. Nagashri et al.sions drawn from these studies lend further support to the
mode of bonding discussed in their IR spectra. The number
of protons calculated from the integration curves and those
obtained from the values of the expected CHN analyses agree
with each other. The 1H and 13C-NMR spectra of the copper
complexes could not be obtained due to their paramagnetic
nature.
3.5. FAB mass spectra
Mass spectra provide a vital clue for elucidating the structure
of the compounds. The mass spectra of the ligand (L1) and its
copper complex [CuL1(H2O)] were recorded and their stoichi-
ometric compositions were compared. The intensity of these
peaks reﬂects the stability and abundance of the ions (Ham-
ming and Foster, 1972). The molecular ion peak for the ligand
(L1) is observed at 424m/z (Fig. 2) whereas its copper complex
shows the molecular ion peak at 515m/z (Fig. 3), which con-
ﬁrms the stoichiometry of the metal complexes to be [CuL1(-
H2O)] type. Elemental analysis values are in close agreement
with the values calculated from molecular formula assigned
to these complexes, which is further supported by the FAB-
mass studies of respective complexes. Similar mass spectral
features were assigned for other ligands and their copper
complexes.Table 2 ESR spectral data of the copper complexes.
Complex g|| g? giso A|| A?
[CuL1(H2O)] at 300 K 2.06
[CuL1(H2O)] at 77 K 2.23 2.06 – 150 44
[CuL2(H2O)] at 300 K 2.10
[CuL2(H2O)] at 77 K 2.21 2.08 – 142 56
[CuL3(H2O)] at 300 K 2.12
[CuL3(H2O)] at 77 K 2.24 2.07 – 154 583.6. ESR spectra
The ESR spectrum of the [CuL1(H2O)] complex was recorded
in DMSO at 300 and 77 K. The spectrum at 300 K shows one
intense absorption band at high ﬁeld, which is isotropic due to
the tumbling motion of the molecules. However, this complex
in the frozen state (77 K) shows four well resolved peaks with
low intensities in the low ﬁeld region and one intense peak in
the high ﬁeld region. The magnetic susceptibility value reveals
that the copper complex has a magnetic moment of 1.92 B.M
corresponding to one unpaired electron, indicating that the
complex is mononuclear in nature. This fact was also evident
from the absence of half ﬁeld signal, observed in the spectrum
at 1600 G due to the Dms = ±2 transitions, ruling out any
Cu–Cu interaction (Gaballa et al., 2007). The ESR spectral
data are given in Table 2.
The f value for cu, Zn SOD is 160 cm indicating a tetrahe-
dral distortion from square planar geometry and is one of the
features that enhances the catalytic activity of the enzyme.
From the above EPR data, the f values for copper complexes
were determined to be in the range of 142–158 cm. Therefore,
our synthesized copper complexes exhibiting appreciable
square planar distortion are expected to show high SOD like
activity. Molecular orbital coefﬁcients a2 (in-plane r-bonding),K|| K? a2 b2 c2 f(g||/A||)
0.90 0.52 0.76 1.34 0.738 148
0.84 0.48 0.72 1.43 0.726 155
0.75 0.46 0.80 1.32 0.841 145
Pharmacological and spectral studies of synthetic biomimetic copper complexes derived from S553b2 (in-plane p-bonding) and c2 (out-plane p-bonding) were
calculated using Eqs. (1)–(3).
a2¼ðAk=0:036Þþðgk 2:0036Þþ3=7ðg?2:0036Þþ0:04 ð1Þ
b2¼ðgk 2:0036ÞE=8ka2 ð2Þ
c2¼ðg2:0036ÞE=2ka2 ð3Þ
The a2 value of 0.5 indicates complete covalent bonding, while
that of 1.0 suggests complete ionic bonding. The observed va-
lue of 0.76 for the present complex indicates that the copper
complex has some covalent character. The observed b2 and
c2 values of 1.34 and 0.738 indicate that there is interaction
in the out-of-plane p-bonding, whereas the in-plane p-bonding
is predominantly ionic. Signiﬁcant information about the nat-
ure of bonding in the Cu(II) complex can be derived from the
relative magnitudes of Kk and K?.
Kk ¼ a2b2 ð4Þ
K? ¼ a2c2 ð5Þ
For the present complex, the observed order:
Kkð0:90Þ > K?ð0:52Þ implies a greater contribution from out-
of plane p-bonding than from in in-plane p-bonding in me-
tal–ligand p bonding.
3.7. Cyclic voltammetry
Cyclic voltammetry is the most versatile electroanalytical tech-
nique for the study of the electroactive species. The important
parameters of a cyclic voltammogram are the magnitudes of
the anodic peak current (ipa), cathodic peak current (ipc), ano-
dic peak potential (Epa) and cathodic peak potential (Epc).
The copper(II) complexes in the DMSO solution undergo
one electron reduction and also one electron oxidation to form
monovalent and trivalent metal species. The electrochemical
behaviours of the Schiff base Cu(II) complexes in DMSO
(0.1 M of TBAP as supporting electrolyte (scan rate 100
mVs1) at 300 K were examined. Table 3 summarizes the
potentials and their assignments, which mainly depend on
the geometry and environment around the copper ion (i.e., li-
gand core).
All copper complexes show well-deﬁned redox couple cor-
responding to copper(II/I). The cathodic peak appearing in
the negative potential of 658–768 mV range corresponds to
the reduction of copper(II) and the corresponding anodic peak
also appears in the negative potential of 658–526 mV which
corresponds to the oxidation of copper(I). The measured
DEp values (116–158 mV) clearly indicate that these redox
couples are quasi-reversible in nature. The ipa/ipc falls at ca.
0.9–1.1, clearly conﬁrming one electron transfer in this redox
process.Table 3 Cyclic voltammetric data of copper complexes.
Complex Epa Epc
[CuL1(H2O)] 0.658 0.766
0.432 –
[CuL2(H2O)] 0.33 0.198
0.632 –
[CuL3(H2O)] 0.316 0.264
0.764 –The cyclic voltammogram of the [CuL1(H2O)] complex in
the DMSO solution at 300 K in the potential range +0.4 to
0.8 V at scan rate 0.1 V s1 was recorded (Fig. 4). It shows
a well deﬁned redox process corresponding to the formation
of the quasi-reversible Cu(II)/Cu(I) couple. The anodic peak
at Epa = 0.065 mV versus Ag/AgCl and the associated
cathodic peak at Epc = 0.076 mV correspond to the Cu(II)/
Cu(I) couple. The [CuL1(OAc)] complex exhibits a quasi-
reversible behaviour.
The cyclic voltammogram of the [CuL2(H2O)] and [CuL
3-
(H2O)] complexes in the DMSO solution at 300 K are shown
in Figs. 4 and 5. On comparing the cyclic voltammograms,
we observed that the variation in oxidation and reduction po-
tential may be due to distortion in the geometry of the com-
plexes which arises due to different donor atoms coordinated
to the copper ion. It is concluded that the present ligand sys-
tems stabilize the unusual oxidation states of copper ion dur-
ing electrolysis. Similar electrochemical behaviour was
observed and assigned for other complexes.
3.8. Thermogravimetric analyses
The thermal decomposition studies of the complexes were
carried in the temperature range 30–600 C with a sample
heating rate 5 C/min in a static nitrogen atmosphere. All
the complexes undergo ﬁrst step decomposition with weight
loss between 220 and 250 C due to loss of the one coordi-
nated water molecule. The complexes show the second step
decomposition between 390 and 420 C due to removal of
half part of the ligand. Finally the complexes undergo
decomposition between 500 and 530 C due to loss of the
remaining part of ligand. The ﬁnal residue was analysed
by IR spectra and identiﬁed as CuO which corresponds to
the calculated value. These features support the formulae
[CuL1(H2O)], [CuL
2(H2O)] and [CuL
3(H2O)], assigned to
the complexes.
3.9. XRD
The crystallite size of the complex was calculated from the
Scherre‘s formula:
dXRD ¼ 0:9k=b cos h;
where k is the wavelength, b is the full-width half maximum of
the characteristic peak and h is the diffraction angle for the hkl
plane.
From the observed dXRD patterns, the average crystallite
sizes for the copolymer [CuL1(H2O)], [CuL
2(H2O)] and
[CuL3(H2O)] complexes are found to be 75, 84 and 62 nm,
respectively.DEp Potential assignment
108 Cu(II)/Cu(I)
– Cu(II)/Cu(III)
154 Cu(II)/Cu(I)
Cu(II)/Cu(III)
140 Cu(II)/Cu(I)
– Cu(II)/Cu(III)
Figure 4 Cyclic voltammogram of [CuL2(H2O)] complex.
Figure 5 Cyclic voltammogram of [CuL3(H2O)] complex.
Table 6 Superoxide dismutase activity of some copper(II)
complexes.
S. no. Complex IC50 (mol dm
1)
1 [CuL1(H2O)] 80
2 [CuL2(H2O)] 68
3 [CuL3(H2O)] 94
S554 K. Nagashri et al.3.10. Antimicrobial activity
To contribute in the ﬁeld of bioinorganic chemistry, conse-
quently, the compounds synthesized have been evaluated for
their antibacterial, antifungal, DNA binding studies. The anti-Table 4 Minimum inhibitory of concentration of the synthesized c
S. no. Compound E. coli K. pneumonia
1 L1 60 64
2 L2 24 26
3 L3 28 36
4 [CuL1(H2O)] 34 38
5 [CuL2(H2O)] 26 28
6 [CuL3(H2O)] 52 54
7 Streptomycin 10 15
Table 5 Minimum inhibition of concentration of the synthesized c
S. no. Compound A. niger R. stolonife
1 L1 60 66
2 L2 19 20
3 L3 24 28
4 [CuL1(H2O)] 28 30
5 [CuL2(H2O)] 32 26
6 [CuL3(H2O)] 52 55
7 Nystatin 10 16bacterial and antifungal tests were carried out using the serial
dilution method.
The in vitro antimicrobial activities of the investigated com-
pounds were tested against the bacterial species S. aureus,
E. coli, K. pneumaniae, P. vulgaris and P. aeruginosa and fun-
gal species A. niger, R. stolonifer, A. ﬂavus, R. bataicola and
C. albicans. The minimum inhibitory concentration (MIC) val-
ues of the compounds are summarized in Tables 4 and 5. A
comparative study of the ligands and their complexes (MIC
values) indicates that complexes exhibit higher antimicrobial
activity than the free ligands. In this study, the antimicrobial
activity of the ligands may be due to the heteroaromatic resi-
dues. Compounds containing >C‚N group have enhanced
antimicrobial activity than >C‚C< group. The growth of
certain microorganisms takes place even in the absence of O2.
The enhanced activity of the complexes can be explained on
the basis of the Overtone’s concept (Anjaneyula and Rao,
1986) and Tweedy’s Chelation theory (Dharamaraj et al.,
2001). Chelation can considerably reduce the polarity of the
metal ion, which in turn increases the lipophilic character of
the chelate. Thus, the interaction between metal ion and the li-
pid is favoured. This may lead to the breakdown of the perme-
ability barrier of the cell, resulting in interference with the
normal cell processes. If the geometry and charge distribution
around the molecule are incompatible with the geometry and
charge distribution around the pores of the bacterial cell wall,ompounds against growth of bacteria (lg/mL).
e P. vulgaris P. aeruginosa S. aureus
66 66 72
20 16 28
26 32 30
32 28 42
30 26 48
58 60 63
6 12 4
ompounds against growth of fungi (lg/mL).
r A. ﬂavus R. bataicola C. albicans
72 80 50
20 25 22
28 34 30
34 38 32
46 36 38
68 80 50
8 14 12
Table 7 Reduction of inﬂammation by prepared compounds
and indomethacin (reference drug) on carrageenin induced rat
paw oedema (CPE%) compared with vehicle treated control
rats.
S. no. Compounds Dose (mmol/kg BMa) CPE%b
1 [CuL1(H2O)] 0.01 26.5
d
2 [CuL2(H2O)] 0.01 64.0
d
3 [CuL3(H2O)] 0.01 32.6
c
Control Indomethacin 0.01 48.3d
(For comparison with controls, Student’s t-test).
a BM= body mass.
b CPE = Carrageenin Paw Oedema.
c p< 0.01.
d p< 0.05.
Pharmacological and spectral studies of synthetic biomimetic copper complexes derived from S555penetration through the wall by the toxic agent cannot take
place and this will prevent the toxic reaction with in the pores.
Chelation is not the only criterion for antibacterial activity.
Some important factors that contribute to the activity are nat-
ure of the metal ion, nature of the ligand, coordinating sites,
geometry of the complex, concentration, hydrophilicity, and
lipophilicity. Certainly, steric, and pharmokinetic factors also
play a decisive role in deciding the potency of an antimicrobial
agent. The higher toxicity of the metal complex can be attrib-
uted to the effect of metal ion on the normal cell processes. The
widespread interaction of metal ions with cellular compounds
is due to the fact that all these structures contain a variety of
functional groups that can act as metal binding ligands. The
problem is how to obtain those interactions in cells and organ-
isms where the non-polar membrane exists to hinder the move-
ment of charged metal ions into the cell, where myriad of metal
binding sites exists to compete for the metal ion, and where
speciﬁcity of cellular interaction must occur in order to obtain
therapeutic value.
Apart from this, the mode of action of these compounds
may also invoke the hydrogen bond though the imine C‚N
group with the active centres and thus interfere with normal
cell processes. Presence of lyphophilic and polar substituents
is expected to enhance antimicrobial activities. Heterocyclic li-
gands with multifunctionality have greater chance of interac-
tion either with nucleoside bases (even after complexation
with metal ion) or with biologically essential metal ions present
in the biosystem which can be promising candidates as bacte-
ricides since they always look to enact especially with some
enzymatic functional groups, to achieve higher coordination
number. Thus, the antibacterial property of metal complexes
cannot be ascribed to chelation alone but it is an intricate
blend of all the above contributions.
3.11. SOD activity
A great deal of interest has been shown in the development
of therapeutic SOD mimetics for the scavenging of superox-
ide (O2 ) which is a precursor to reactive oxygen and nitro-
gen species (RONS) known to contribute to oxidative stress.
The SOD mimetic activities of the copper(II) complexes were
determined and compiled in Table 6. In the present study,
[CuL3(H2O)] has higher SOD activity as compared to other
complexes. A greater interaction between superoxide ionand Cu(II) complex is induced due to the stronger axial
bond, which results in an increased catalytic activity. In
addition azomethine ligands containing electron withdrawing
substituent stabilizes the Cu(I) complex formed during super-
oxide dismutation reaction which further reacts with super-
oxide ion to give hydrogen peroxide. The distorted
geometry of these complexes may favour the geometrical
change, which is essential for the catalysis as the geometry
of copper in the SOD enzyme also changes from distorted
square planar geometry. The difference in reactivities of
the synthesized complexes may be attributed to the coordina-
tion environment and the redox potential of the couple Cu+/
Cu++ in copper(II) complexes during the catalytic cycle. It
has been reported that the redox potential of copper(II) ions
is affected by the coordination structure of copper(II) com-
plexes (Dı´az et al., 2009) (see Table 7).
3.12. Anti-inﬂammatory activity
The reference drug, indomethacin, is a non-steroidal anti-
inﬂammatory drug, which is used for the treatment of a broad
spectrum of inﬂammation related diseases suggested to be due
to inhibition of prostaglandin syntheses. The initial phase is
attributed to the release of histamine and serotonin. The oede-
ma maintained between the ﬁrst and the second phase is due to
kinin like substances (Lazzaroni and Bianchi Porro, 2004). The
second phase is said to be promoted by prostaglandin like sub-
stances. It has been reported that the second phase of oedema
is sensitive to drugs like hydrocortisone, phenylbutazone and
indomethacin. The results show that the copper complex which
has higher activity than other complexes is due to the high dif-
fusion of the copper complex.
4. Conclusion
In conclusion, the synthesized 3-hydroxyﬂavone derivatives
can be potentially useful for anti-inﬂammatory agents that
can prompt future researchers to synthesise a series of 3-
hydroxyﬂavone derivatives which contains wide variety of sub-
stituents with the aim of obtaining novel heterocyclic (biosen-
sitive) compounds with enhanced activity.Acknowledgements
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